These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11737892)

  • 21. The AP-2 family of transcription factors.
    Eckert D; Buhl S; Weber S; Jäger R; Schorle H
    Genome Biol; 2005; 6(13):246. PubMed ID: 16420676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis.
    Chang X; Gao JX; Jiang Q; Wen J; Seifers N; Su L; Godfrey VL; Zuo T; Zheng P; Liu Y
    J Exp Med; 2005 Oct; 202(8):1141-51. PubMed ID: 16230479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.
    Lanteri M; Ollier L; Giordanengo V; Lefebvre JC
    Breast Cancer Res; 2005; 7(4):R487-94. PubMed ID: 15987454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.
    Vernimmen D; Begon D; Salvador C; Gofflot S; Grooteclaes M; Winkler R
    Biochem J; 2003 Feb; 370(Pt 1):323-9. PubMed ID: 12418962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting HER2: recent developments and future directions for breast cancer patients.
    Wang SC; Zhang L; Hortobagyi GN; Hung MC
    Semin Oncol; 2001 Dec; 28(6 Suppl 18):21-9. PubMed ID: 11774202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment.
    Hurst HC
    Breast Cancer Res; 2001; 3(6):395-8. PubMed ID: 11737892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
    Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
    Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells.
    Delacroix L; Begon D; Chatel G; Jackers P; Winkler R
    DNA Cell Biol; 2005 Sep; 24(9):582-94. PubMed ID: 16153159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members.
    Olayioye MA
    Breast Cancer Res; 2001; 3(6):385-9. PubMed ID: 11737890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers.
    Vernimmen D; Gueders M; Pisvin S; Delvenne P; Winkler R
    Br J Cancer; 2003 Sep; 89(5):899-906. PubMed ID: 12942124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
    Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
    Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ets regulation of the erbB2 promoter.
    Scott GK; Chang CH; Erny KM; Xu F; Fredericks WJ; Rauscher FJ; Thor AD; Benz CC
    Oncogene; 2000 Dec; 19(55):6490-502. PubMed ID: 11175365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies.
    Yu D; Hung MC
    Oncogene; 2000 Dec; 19(53):6115-21. PubMed ID: 11156524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.
    Bates NP; Hurst HC
    J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):153-63. PubMed ID: 10882301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides.
    Chiang SY; Burli RW; Benz CC; Gawron L; Scott GK; Dervan PB; Beerman TA
    J Biol Chem; 2000 Aug; 275(32):24246-54. PubMed ID: 10818092
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.